rs116826217
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_015340.4(LARS2):c.1552G>A(p.Asp518Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00595 in 1,613,938 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. D518D) has been classified as Likely benign.
Frequency
Consequence
NM_015340.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LARS2 | NM_015340.4 | c.1552G>A | p.Asp518Asn | missense_variant | 14/22 | ENST00000645846.2 | |
LARS2-AS1 | NR_048543.1 | n.261-803C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LARS2 | ENST00000645846.2 | c.1552G>A | p.Asp518Asn | missense_variant | 14/22 | NM_015340.4 | P1 | ||
LARS2-AS1 | ENST00000442534.2 | n.261-803C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes ? AF: 0.00444 AC: 675AN: 152194Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00381 AC: 958AN: 251478Hom.: 4 AF XY: 0.00386 AC XY: 524AN XY: 135910
GnomAD4 exome AF: 0.00611 AC: 8925AN: 1461626Hom.: 37 Cov.: 30 AF XY: 0.00599 AC XY: 4357AN XY: 727118
GnomAD4 genome ? AF: 0.00442 AC: 673AN: 152312Hom.: 4 Cov.: 32 AF XY: 0.00409 AC XY: 305AN XY: 74490
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 05, 2019 | This variant is associated with the following publications: (PMID: 32442335) - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 25, 2022 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2024 | LARS2: BS2 - |
not specified Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Aug 06, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 24, 2014 | Asp518Asn in exon 14 of LARS2: This variant is not expected to have clinical sig nificance because it has been identified in 0.8% (67/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs116826217). - |
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 30, 2017 | - - |
Inborn mitochondrial myopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Kids Research, The Children's Hospital at Westmead | Jul 18, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at